Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Product sales, net	$ 9,491,569	$ 10,333,090
Cost of products sold	3,048,260	3,630,765
Gross profit	6,443,309	6,702,325
Selling, general and administrative expenses	9,399,201	7,404,258
Research and development expenses	100,856	88,243
Total operating expenses	9,500,057	7,492,501
Loss from operations	(3,056,748)	(790,176)
Other (expenses)	(5,347)
Interest income	3,838	2,389
Total other expenses, net	(1,509)	2,389
Loss before provision for income tax and equity in net earnings of equity investments	(3,058,257)	(787,787)
Provision for income tax	(36,157)	(9,509)
Loss before equity in net earnings of equity investments	(3,094,414)	(797,296)
Net loss in equity investments	(2,445,489)	(910,200)
Net Loss	(5,539,903)	(1,707,496)
Net loss attributable to noncontrolling interests	72,381	5,472
Net loss attributable to Milestone Scientific Inc.	$ (5,467,522)	$ (1,702,024)
Net loss per share applicable to common stockholders—
Basic	$ (0.26)	$ (0.08)
Diluted	$ (0.26)	$ (0.08)
Weighted average shares outstanding and to be issued—
Basic	21,429,993	20,063,513
Diluted	21,429,993	20,063,513
Milestone Medical Inc. [Member]
Product sales, net	$ 51,000	$ 0
Total operating expenses	3,990,000	1,900,000
Net loss in equity investments	(2,019,211)	(891,500)
Milestone Education LLC [Member]
Net loss in equity investments	(7,846)	(17,890)
Net Loss	(7,846)	(17,889)
Milestone China [Member]
Net loss in equity investments	(348,651)	(810)
Loss on earnings from China Joint Venture	$ (418,432)	$ (810)